1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Impact of Cellularity on Oncologic Outcomes Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemoperfusion for Pseudomyxoma Peritonei.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The Peritoneal Surface Oncology Group International (PSOGI) recommends pathologic reporting of tumor cellularity in patients with pseudomyxoma peritonei (PMP) undergoing cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion (CRS-HIPEC). We investigated the prognostic significance of PMP cellularity, or lack thereof (acellular mucin), following CRS-HIPEC.

          Related collections

          Author and article information

          Journal
          Ann Surg Oncol
          Annals of surgical oncology
          Springer Science and Business Media LLC
          1534-4681
          1068-9265
          Jan 2018
          : 25
          : 1
          Affiliations
          [1 ] Division of Surgical Oncology, Koch Regional Perfusion Center, University of Pittsburgh, Pittsburgh, PA, USA. choudrymh@upmc.edu.
          [2 ] Department of Pathology, University of Pittsburgh, Pittsburgh, PA, USA.
          [3 ] The University of Pittsburgh Cancer Institute Biostatistics Facility, Pittsburgh, PA, USA.
          [4 ] Division of Surgical Oncology, Koch Regional Perfusion Center, University of Pittsburgh, Pittsburgh, PA, USA.
          Article
          10.1245/s10434-017-6214-7
          10.1245/s10434-017-6214-7
          29110275
          c303109b-dc2c-456d-bedc-828cbf1c7714
          History

          Comments

          Comment on this article